Biomarkers in MS
Across
- 2. Imaging technique used to identify lesions and volume loss
- 4. Biomarker frequently assessed from bodily fluids
- 6. Imaging method for observing spinal cord lesions
- 7. located largely within the hippocampus and frontal lobes
- 10. May predict conversion from CIS to MS
- 11. May help inform treatment course
- 13. Measures degeneration of the optic nerve
- 15. Used to identify at-risk individuals
- 16. Structural protein in axons
- 17. Characterized by inflammatory demyelination, remyelination failure, and axonal degeneration
Down
- 1. Popular imaging biomarker used to diagnose MS and evaluate disease activity
- 3. Up to 90% of patients with MS have these in the CSF
- 5. Helps differentiate between diseases
- 8. Biomarker used to complement clinical assessments
- 9. Used to evaluate the presence of OCB
- 10. Intermediate filament found in astrocytes, associated with higher T2 lesion load
- 12. may quantitatively evaluate microglial activation within NAWM
- 14. could identify threat of treatment failure